Maher Awar, MD
Cardiology · Yuma, AZNPI 1124052154
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,997 of the $4,806 with a category attached, or 83.2%. 22 manufacturers reported payments, led by Endologix LLC at 27.3% of the total.
Across 118 payments — averaging $40.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Endologix LLC$1K
- Medtronic$1K
- Boston Scientific$826
- Edwards Lifesciences$305
- Amgen$236
- Silk Road Medical, Inc.$220
- plus $669 from 16 others
What the payments were for
- Travel & lodging$81017%
- Food & beverage$3,99783%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Endologix LLC | 6 | $1,311 |
| Medtronic(2 entities) | 36 | $1,240 |
| Boston Scientific | 27 | $826 |
| Edwards Lifesciences | 2 | $305 |
| Amgen | 13 | $236 |
| Silk Road Medical, Inc. | 2 | $220 |
| Abiomed | 4 | $105 |
| Novartis | 5 | $93 |
| Baxter Healthcare | 1 | $67 |
| Actelion Pharmaceuticals US, Inc. | 3 | $52 |
| AstraZeneca | 3 | $48 |
| Boehringer Ingelheim | 2 | $43 |
| Abbott | 2 | $43 |
| E.r. Squibb & Sons, L.L.C. | 3 | $41 |
| Pfizer | 2 | $41 |
| Bayer | 1 | $26 |
| Alnylam Pharmaceuticals Inc. | 1 | $25 |
| Philips North America LLC | 1 | $22 |
| Cardiovascular Systems Inc. | 1 | $18 |
| Johnson & Johnson | 1 | $16 |
| Preventice Services, LLC | 1 | $15 |
| Terumo Medical Corporation | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Torus Stent Graft System$1,039
- ENDOCROSS Device$1,039
- ENROUTE Transcarotid Stent$166
- ENROUTE Transcarotid Neuroprotection System$166
- SAPIEN 3 Ultra RESILIA$162
- Edwards SAPIEN 3 Transcatheter Heart Valve$143
- Alto Abdominal Stent Graft System$130
- WATCHMAN FLX$128
- Repatha$124
- CoreValve Evolut$113
- Micra$110
- Protege RX$105
- AFX2 Bifurcated Endograft System$105
How this compares
Too few cardiology providers in Arizonato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 220 | $306,362 |
| EntrestoSacubitril/Valsartan | 66 | $99,927 |
| Repatha SureclickEvolocumab | 91 | $82,419 |
| XareltoRivaroxaban | 38 | $45,882 |
| FarxigaDapagliflozin Propanediol | 17 | $25,441 |
| BrilintaTicagrelor | 28 | $23,904 |
| MultaqDronedarone Hcl | 15 | $20,859 |
| Repatha SyringeEvolocumab | 13 | $8,371 |
| ClopidogrelClopidogrel Bisulfate | 467 | $6,926 |
| Atorvastatin Calcium | 430 | $4,590 |
| Metoprolol Succinate | 161 | $2,632 |
| Ezetimibe | 79 | $2,479 |
| Potassium Chloride | 97 | $2,475 |
| Amiodarone Hcl | 63 | $2,219 |
| Midodrine Hcl | 14 | $2,198 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $41 | $306,362220 claims |
| NovartisEntresto | $93 | $99,92766 claims |
| AstraZenecaFarxiga, Brilinta | $48 | $49,34545 claims |
| Johnson & JohnsonXarelto | $16 | $45,88238 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. There are too few cardiology providers in Arizonaon file to place this against a meaningful peer group, so we don't.
Other cardiology in Yuma
- Habteab FesehaYuma$18K
- Tri NguyenPhoenix$12K
- Paul DuongPhoenix$11K
- Nitin PatelPrescott Valley$2K
- Douglas RothrockPrescott$156
- Frederick SimonieScottsdale$74
- Carolyn LarsenScottsdale$0
- Susan Wilansky MarkowitzScottsdale$0
- Gerald WolffTucson$0
- Abdul TajikScottsdale$0
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.